The expression of MATN1-AS1 and miR-200b was higher in patients with poor differentiation, tumor size ≥ 4 cm, FIGO stage III–IV, and there was lymph node metastasis (P < 0.05) (Table 3). The gene discussed is MATN1; the disease is metastatic malignant neoplasm in the lymph nodes.